Science Explorer Back to mapMap
Discussion
Company · Manassas · United States

Serpin Pharma (United States)

serpinpharma.comROR OpenAlex
Research works
3
▲ 67% vs 2018-21
Citations
67
19.3 per fractional work
Top-10% rate
5.5%
all institutions 10.0%
Open access
94%
world 40%
International
22%
world 18%
Serpin Pharma (United States)

Not ranked overall: Serpin Pharma (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Serpin Pharma (United States) work in?

In all years, 63% of research at Serpin Pharma (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (63%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (14%). It does 1.4× the world's share of Health Sciences.

Health Sciences: 2 fractional works · 62.9% of its workMedicine: 2 fractional works · 62.9% of its workLife Sciences: 1 fractional works · 37.1% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 17.1% of its workImmunology and Microbiology: 0 fractional works · 14.3% of its workNeuroscience: 0 fractional works · 5.7% of its workALL ITS WORKSerpin Pharma(United States)4fractional works, all years
Life Sciences37%Health Sciences63%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers
    1. Medicine262.9%
    1. Biochemistry, Genetics and Molecular Biology117.1%
    2. Immunology and Microbiology014.3%
    3. Neuroscience05.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at Serpin Pharma (United States)?

Ranked on the quality score, Cohava Gelber lead among researchers whose main affiliation is Serpin Pharma (United States).

  1. 1 Cohava Gelber United States · #4,001,520 worldwide 810 citations · 27 works
All ranked researchers at Serpin Pharma (United States)

What are the most cited papers from Serpin Pharma (United States)?

The most cited paper from Serpin Pharma (United States) is "The Role of IKKβ in Venezuelan Equine Encephalitis Virus Infection" (Moushimi Amaya, Kelsey Voss, Gavin C. Sampey et al., 2014), with 47 citations. Next come "Low-Density Lipoprotein Receptor–Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction" (45) and "Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription" (27).

Most cited papers
#PaperReleasedCitations
1 The Role of IKKβ in Venezuelan Equine Encephalitis Virus Infection Moushimi Amaya, Kelsey Voss, Gavin C. Sampey et al. · PLoS ONE Open access 19 Feb 2014 47
2 Low-Density Lipoprotein Receptor–Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction Stefano A Toldo, Dana Austin, Adolfo Gabriele Mauro et al. · JACC Basic to Translational Science Open access Oct 2017 45
3 Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription Catherine DeMarino, Maria Cowen, Pooja Khatkar et al. · Cells Open access 18 Feb 2022 27
4 α1‐Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain Zixuan Wang, Stefano Martellucci, Alicia Van Enoo et al. · The FASEB Journal Open access 9 Dec 2021 16
5 A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers George F. Wohlford, Leo Francis Buckley, Dinesh Kadariya et al. · PLoS ONE Open access 6 May 2021 16
All 10 most cited papers, with filters and sorting

Which research topics does Serpin Pharma (United States) publish most on?

By volume in 2022-now: HIV Research and Treatment, HIV-related health complications and treatments, Immune cells in cancer and Atherosclerosis and Cardiovascular Diseases.

HIV Research and Treatment0HIV Research and Treatment: 0 fractional worksHIV-related health compl…0HIV-related health complications and treatments: 0 fractional worksImmune cells in cancer: 0 fractional worksAtherosclerosis and Cardiovascular Diseases: 0 fractional worksAdipokines, Inflammation…0Adipokines, Inflammation, and Metabolic Diseases: 0 fractional worksCardiac and Coronary Surgery Techniques: 0 fractional worksAcute Kidney Injury Research: 0 fractional worksCardiac, Anesthesia and …0Cardiac, Anesthesia and Surgical Outcomes: 0 fractional worksNeuroinflammation and Neurodegeneration Mechanisms: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional works
VirologyEmergency MedicineImmunologyEpidemiology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HIV Research and Treatment Virology 0 works
  2. 2 HIV-related health complications and treatments Emergency Medicine 0 works
  3. 3 Immune cells in cancer Immunology 0 works
  4. 4 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
  5. 5 Adipokines, Inflammation, and Metabolic Diseases Epidemiology 0 works
  6. 6 Cardiac and Coronary Surgery Techniques Surgery 0 works
  7. 7 Acute Kidney Injury Research Nephrology 0 works
  8. 8 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 0 works
  9. 9 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available94.2%not open5.8%

World: 40% of research is openly available.

with international co-authors22.3%domestic only77.7%

World: 18% is written across borders.

How has Serpin Pharma (United States)'s research output changed?

Output in 2022-2025 was 67% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Manassas

All research institutions in Manassas

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Serpin Pharma (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.